CDC Issues Update on Managing Shigella Treated with Certain Antibiotics
The Centers for Disease Control and Prevention today issued updated recommendations for managing and reporting Shigella infections that were treated with ciprofloxacin or azithromycin and resulted in possible clinical treatment failure. “If treatment failure is suspected, clinicians should consider consulting an infectious disease specialist to identify best treatment options, and submit a stool specimen for antimicrobial susceptibility testing,” CDC said. “Clinicians should monitor patients carefully and report cases of possible clinical treatment failure to CDC.” Shigella bacteria can cause Shigellosis, a diarrheal disease that should be reported to local health departments.
Related News Articles
Headline
Updated prostate cancer screening guidelines issued Nov. 12 by the American Cancer Society recommend prostate-specific antigen-based blood testing every two…
Headline
A study released Nov. 5 by the National Institutes of Health found that women with higher blood levels of two common per- and polyfluoroalkyl substances, or…
Headline
A study conducted by the University of Utah examined variations in risk behaviors for colorectal, cervical and breast cancer and trends in screening across…
Headline
The Department of Health and Human Services Oct. 27 announced a new initiative to improve breast cancer screening and detection efforts. The initiative, led by…
Headline
The Department of Health and Human Services Oct. 20 launched a national plan focused on kidney care. HHS said the plan would address the root cause of kidney…
Headline
The Centers for Medicare & Medicaid Services Sept. 15 announced an expansion of its outcome-aligned payment model offering technology-supported care to…